U.S. federal trademark · Serial No. 98342071
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; all of the foregoing excluding therapeutic pharmaceuticals for hair growth, skin health, and sexual dysfunction and compounded pharmaceuticals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.